{
"info": {
"nct_id": "NCT00909831",
"official_title": "A Phase I Trial of Hydroxychloroquine in Combination With Temsirolimus in Patients With Refractory Solid Tumors",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 120 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed refractory solid tumor for which no curative standard therapy exists\n\n * Metastatic disease\n* Treated brain metastases that have been stable ≥ 3 months allowed\n\n * At least 1 week since prior steroids\n\nPATIENT CHARACTERISTICS:\n\n* ECOG performance status of 0-1\n* ANC ≥ 1,500/mm^3\n* Platelet count ≥ 100,000/mm^3\n* Creatinine ≤ 2 times upper limit of normal (ULN)\n* ALT and AST ≤ 5 times ULN\n* Total bilirubin ≤ 1.5 mg/dL\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No serious concurrent infection or medical illness that would jeopardize the ability of the patient to receive the treatment outlined in this protocol with reasonable safety\n* No prior or other concurrent malignancy except for curatively treated carcinoma-in-situ at any site or basal cell carcinoma or squamous cell carcinoma of the skin\n\n * Patients who have been free of disease (any prior malignancy) for ≥ 5 years are eligible\n* No porphyria\n* No psoriasis, except well controlled psoriasis under the care of a specialist\n* No previously documented macular degeneration or diabetic retinopathy\n* No HIV positivity\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* Any number and type of prior anticancer therapies allowed\n* No prior mTOR inhibitors\n* At least 4 weeks since prior immunotherapy (i.e., aldesleukin, interferon, CTLA-4) or chemotherapy and recovered\n* At least 2 weeks since prior oral targeted therapy and recovered\n* At least 4 weeks since prior and no other concurrent investigational anticancer therapy (except for vaccines)\n* No other concurrent therapy\n* No concurrent combination antiretroviral therapy for HIV-positive patients\n* No concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs (i.e., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)\n* Concurrent non-enzyme inducing anticonvulsants, including felbamate, valproic acid, gabapentin, lamotrigine, tiagabine, topiramate, zonisamide, or levetiracetam allowed\n* Concurrent hematologic growth factors (filgrastim [G-CSF], pegfilgrastim, epoetin alfa) allowed in patients with severe myelosuppression"
},
"inclusion_lines": [
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 120 Years",
"criterions": [
{
"exact_snippets": "maximum age of 120 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 120,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 120 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 120,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"identified_line": {
"line": "DISEASE CHARACTERISTICS:",
"criterions": [
{
"exact_snippets": "DISEASE CHARACTERISTICS",
"criterion": "disease characteristics",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "DISEASE CHARACTERISTICS",
"criterion": "disease characteristics",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
}
},
{
"identified_line": {
"line": "* Histologically confirmed refractory solid tumor for which no curative standard therapy exists",
"criterions": [
{
"exact_snippets": "Histologically confirmed refractory solid tumor",
"criterion": "refractory solid tumor",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically"
}
},
{
"exact_snippets": "no curative standard therapy exists",
"criterion": "curative standard therapy",
"requirement": {
"requirement_type": "existence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Histologically confirmed refractory solid tumor",
"criterion": "refractory solid tumor",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically"
}
},
{
"exact_snippets": "no curative standard therapy exists",
"criterion": "curative standard therapy",
"requirement": {
"requirement_type": "existence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Metastatic disease",
"criterions": [
{
"exact_snippets": "Metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Treated brain metastases that have been stable ≥ 3 months allowed",
"criterions": [
{
"exact_snippets": "Treated brain metastases ... stable ≥ 3 months",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "treatment",
"expected_value": true
}
},
{
"exact_snippets": "Treated brain metastases ... stable ≥ 3 months",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "stability duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Treated brain metastases ... stable ≥ 3 months",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "treatment",
"expected_value": true
}
},
{
"exact_snippets": "Treated brain metastases ... stable ≥ 3 months",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "stability duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* At least 1 week since prior steroids",
"criterions": [
{
"exact_snippets": "At least 1 week since prior steroids",
"criterion": "time since prior steroids",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "week"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "At least 1 week since prior steroids",
"criterion": "time since prior steroids",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "week"
}
}
}
]
}
},
{
"identified_line": {
"line": "* ECOG performance status of 0-1",
"criterions": [
{
"exact_snippets": "ECOG performance status of 0-1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG performance status of 0-1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* ANC ≥ 1,500/mm^3",
"criterions": [
{
"exact_snippets": "ANC ≥ 1,500/mm^3",
"criterion": "ANC",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm^3"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ANC ≥ 1,500/mm^3",
"criterion": "ANC",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm^3"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Platelet count ≥ 100,000/mm^3",
"criterions": [
{
"exact_snippets": "Platelet count ≥ 100,000/mm^3",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm^3"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Platelet count ≥ 100,000/mm^3",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm^3"
}
}
}
]
}
},
{
"identified_line": {
"line": "* ALT and AST ≤ 5 times ULN",
"criterions": [
{
"exact_snippets": "ALT ... ≤ 5 times ULN",
"criterion": "ALT",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
},
{
"exact_snippets": "AST ≤ 5 times ULN",
"criterion": "AST",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ALT ... ≤ 5 times ULN",
"criterion": "ALT",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
},
{
"exact_snippets": "AST ≤ 5 times ULN",
"criterion": "AST",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Negative pregnancy test",
"criterions": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
}
]
}
},
{
"identified_line": {
"line": "* Fertile patients must use effective contraception",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirement": {
"requirement_type": "status",
"expected_value": "fertile"
}
},
{
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "necessity",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirement": {
"requirement_type": "status",
"expected_value": "fertile"
}
},
"then_criteria": {
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "necessity",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* No serious concurrent infection or medical illness that would jeopardize the ability of the patient to receive the treatment outlined in this protocol with reasonable safety",
"criterions": [
{
"exact_snippets": "No serious concurrent infection",
"criterion": "serious concurrent infection",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No serious ... medical illness that would jeopardize the ability of the patient to receive the treatment",
"criterion": "serious medical illness",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No serious concurrent infection",
"criterion": "serious concurrent infection",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No serious ... medical illness that would jeopardize the ability of the patient to receive the treatment",
"criterion": "serious medical illness",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* No prior or other concurrent malignancy except for curatively treated carcinoma-in-situ at any site or basal cell carcinoma or squamous cell carcinoma of the skin",
"criterions": [
{
"exact_snippets": "No prior or other concurrent malignancy",
"criterion": "prior malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No prior or other concurrent malignancy",
"criterion": "concurrent malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "except for curatively treated carcinoma-in-situ at any site",
"criterion": "curatively treated carcinoma-in-situ",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "except for ... basal cell carcinoma",
"criterion": "basal cell carcinoma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "except for ... squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"not_criteria": {
"exact_snippets": "No prior or other concurrent malignancy",
"criterion": "prior malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
},
{
"not_criteria": {
"exact_snippets": "No prior or other concurrent malignancy",
"criterion": "concurrent malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "except for curatively treated carcinoma-in-situ at any site",
"criterion": "curatively treated carcinoma-in-situ",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "except for ... basal cell carcinoma",
"criterion": "basal cell carcinoma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "except for ... squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Patients who have been free of disease (any prior malignancy) for ≥ 5 years are eligible",
"criterions": [
{
"exact_snippets": "free of disease (any prior malignancy) for ≥ 5 years",
"criterion": "disease-free duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "free of disease (any prior malignancy) for ≥ 5 years",
"criterion": "disease-free duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* No porphyria",
"criterions": [
{
"exact_snippets": "No porphyria",
"criterion": "porphyria",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No porphyria",
"criterion": "porphyria",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* No psoriasis, except well controlled psoriasis under the care of a specialist",
"criterions": [
{
"exact_snippets": "No psoriasis",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "well controlled psoriasis under the care of a specialist",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "control",
"expected_value": "well controlled"
}
},
{
"exact_snippets": "well controlled psoriasis under the care of a specialist",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "care",
"expected_value": "under the care of a specialist"
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "No psoriasis",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"then_criteria": null,
"else_criteria": {
"and_criteria": [
{
"exact_snippets": "well controlled psoriasis under the care of a specialist",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "control",
"expected_value": "well controlled"
}
},
{
"exact_snippets": "well controlled psoriasis under the care of a specialist",
"criterion": "psoriasis",
"requirement": {
"requirement_type": "care",
"expected_value": "under the care of a specialist"
}
}
]
}
}
},
{
"identified_line": {
"line": "* No prior mTOR inhibitors",
"criterions": [
{
"exact_snippets": "No prior mTOR inhibitors",
"criterion": "prior mTOR inhibitors",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No prior mTOR inhibitors",
"criterion": "prior mTOR inhibitors",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* At least 4 weeks since prior immunotherapy (i.e., aldesleukin, interferon, CTLA-4) or chemotherapy and recovered",
"criterions": [
{
"exact_snippets": "At least 4 weeks since prior immunotherapy (i.e., aldesleukin, interferon, CTLA-4)",
"criterion": "time since prior immunotherapy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "At least 4 weeks since prior ... chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior treatment",
"requirement": {
"requirement_type": "status",
"expected_value": "recovered"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "At least 4 weeks since prior immunotherapy (i.e., aldesleukin, interferon, CTLA-4)",
"criterion": "time since prior immunotherapy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior treatment",
"requirement": {
"requirement_type": "status",
"expected_value": "recovered"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "At least 4 weeks since prior ... chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior treatment",
"requirement": {
"requirement_type": "status",
"expected_value": "recovered"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* At least 2 weeks since prior oral targeted therapy and recovered",
"criterions": [
{
"exact_snippets": "At least 2 weeks since prior oral targeted therapy",
"criterion": "time since prior oral targeted therapy",
"requirement": {
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior therapy",
"requirement": {
"requirement_type": "status",
"expected_value": "recovered"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "At least 2 weeks since prior oral targeted therapy",
"criterion": "time since prior oral targeted therapy",
"requirement": {
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior therapy",
"requirement": {
"requirement_type": "status",
"expected_value": "recovered"
}
}
]
}
},
{
"identified_line": {
"line": "* At least 4 weeks since prior and no other concurrent investigational anticancer therapy (except for vaccines)",
"criterions": [
{
"exact_snippets": "At least 4 weeks since prior ... investigational anticancer therapy",
"criterion": "time since prior investigational anticancer therapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "no other concurrent investigational anticancer therapy",
"criterion": "concurrent investigational anticancer therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "(except for vaccines)",
"criterion": "concurrent investigational anticancer therapy",
"requirement": {
"requirement_type": "exception",
"expected_value": "vaccines"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "At least 4 weeks since prior ... investigational anticancer therapy",
"criterion": "time since prior investigational anticancer therapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"or_criteria": [
{
"exact_snippets": "no other concurrent investigational anticancer therapy",
"criterion": "concurrent investigational anticancer therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "(except for vaccines)",
"criterion": "concurrent investigational anticancer therapy",
"requirement": {
"requirement_type": "exception",
"expected_value": "vaccines"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* No other concurrent therapy",
"criterions": [
{
"exact_snippets": "No other concurrent therapy",
"criterion": "concurrent therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No other concurrent therapy",
"criterion": "concurrent therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterions": [
{
"exact_snippets": "No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterion": "combination antiretroviral therapy",
"requirement": {
"requirement_type": "concurrency",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterion": "combination antiretroviral therapy",
"requirement": {
"requirement_type": "concurrency",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* No concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs (i.e., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)",
"criterions": [
{
"exact_snippets": "No concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs (i.e., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)",
"criterion": "concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs (i.e., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)",
"criterion": "concurrent cytochrome P450 enzyme-inducing anticonvulsant drugs",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* Concurrent non-enzyme inducing anticonvulsants, including felbamate, valproic acid, gabapentin, lamotrigine, tiagabine, topiramate, zonisamide, or levetiracetam allowed",
"criterions": [
{
"exact_snippets": "Concurrent non-enzyme inducing anticonvulsants, including felbamate, valproic acid, gabapentin, lamotrigine, tiagabine, topiramate, zonisamide, or levetiracetam allowed",
"criterion": "concurrent non-enzyme inducing anticonvulsants",
"requirement": {
"requirement_type": "allowed",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Concurrent non-enzyme inducing anticonvulsants, including felbamate, valproic acid, gabapentin, lamotrigine, tiagabine, topiramate, zonisamide, or levetiracetam allowed",
"criterion": "concurrent non-enzyme inducing anticonvulsants",
"requirement": {
"requirement_type": "allowed",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Concurrent hematologic growth factors (filgrastim [G-CSF], pegfilgrastim, epoetin alfa) allowed in patients with severe myelosuppression",
"criterions": [
{
"exact_snippets": "Concurrent hematologic growth factors (filgrastim [G-CSF], pegfilgrastim, epoetin alfa) allowed",
"criterion": "use of hematologic growth factors",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "patients with severe myelosuppression",
"criterion": "severe myelosuppression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "patients with severe myelosuppression",
"criterion": "severe myelosuppression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"then_criteria": {
"exact_snippets": "Concurrent hematologic growth factors (filgrastim [G-CSF], pegfilgrastim, epoetin alfa) allowed",
"criterion": "use of hematologic growth factors",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "PATIENT CHARACTERISTICS:",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
},
{
"identified_line": {
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
}
]
}
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"identified_line": {
"line": "* Creatinine ≤ 2 times upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Creatinine ≤ 2 times upper limit of normal (ULN)",
"criterion": "creatinine level",
"requirement": {
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "times ULN"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Creatinine \u0010 2 times upper limit of normal (ULN)",
"criterion": "creatinine level",
"requirement": {
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "times ULN"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Total bilirubin ≤ 1.5 mg/dL",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤ 1.5 mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Total bilirubin \u0010.5 mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* No previously documented macular degeneration or diabetic retinopathy",
"criterions": [
{
"exact_snippets": "No previously documented macular degeneration",
"criterion": "macular degeneration",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No previously documented ... diabetic retinopathy",
"criterion": "diabetic retinopathy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* No HIV positivity",
"criterions": [
{
"exact_snippets": "No HIV positivity",
"criterion": "HIV status",
"requirement": {
"requirement_type": "positivity",
"expected_value": false
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "PRIOR CONCURRENT THERAPY:",
"criterions": [
{
"exact_snippets": "PRIOR CONCURRENT THERAPY",
"criterion": "prior concurrent therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* See Disease Characteristics",
"criterions": [
{
"exact_snippets": "Disease Characteristics",
"criterion": "disease characteristics",
"requirement": {
"requirement_type": "N/A",
"expected_value": "see details"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Any number and type of prior anticancer therapies allowed",
"criterions": [
{
"exact_snippets": "Any number and type of prior anticancer therapies allowed",
"criterion": "prior anticancer therapies",
"requirement": {
"requirement_type": "number",
"expected_value": "any"
}
},
{
"exact_snippets": "Any number and type of prior anticancer therapies allowed",
"criterion": "prior anticancer therapies",
"requirement": {
"requirement_type": "type",
"expected_value": "any"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
]
}